Do analysts rate BFRG or HBIO?

Harvard Bioscience has a consensus price target of $6.00, indicating a potential downside of 7.26%. Given Harvard Bioscience's stronger consensus rating and higher possible upside, analysts clearly believe Harvard Bioscience is more favorable than Bullfrog AI. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bullfrog AI 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Harvard Bioscience 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts recommend BNGO or BFRG?

Bionano Genomics currently has a consensus price target of $6.00, suggesting a potential upside of 417.24%. Given Bionano Genomics' stronger consensus rating and higher possible upside, equities research analysts plainly believe Bionano Genomics is more favorable than Bullfrog AI. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bionano Genomics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Bullfrog AI 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is BNGO or BFRG more profitable?

Bullfrog AI has a net margin of 0.00% compared to Bionano Genomics' net margin of -109.94%. Bionano Genomics' return on equity of -71.38% beat Bullfrog AI's return on equity. Company Net Margins Return on Equity Return on Assets Bionano Genomics -109.94% -71.38% -43.07% Bullfrog AI N/A -217.80% -174.57%

Do analysts rate BFRG or ISPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bullfrog AI 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is BFRG or ISPC more profitable?

Bullfrog AI has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. Bullfrog AI's return on equity of -217.80% beat iSpecimen's return on equity. Company Net Margins Return on Equity Return on Assets Bullfrog AI N/A -217.80% -174.57% iSpecimen -1,080.16% -584.65% -142.48%

Do analysts prefer BFRG or VIVS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bullfrog AI 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 VivoSim Labs 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is BFRG or VIVS more profitable?

Bullfrog AI has a net margin of 0.00% compared to VivoSim Labs' net margin of -10,567.17%. Bullfrog AI's return on equity of -217.80% beat VivoSim Labs' return on equity. Company Net Margins Return on Equity Return on Assets Bullfrog AI N/A -217.80% -174.57% VivoSim Labs -10,567.17% -277.62% -153.77%

Do analysts prefer BFRG or TBIO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bullfrog AI 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Telesis Bio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is BFRG or TBIO more profitable?

Bullfrog AI has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Telesis Bio's return on equity of 0.00% beat Bullfrog AI's return on equity. Company Net Margins Return on Equity Return on Assets Bullfrog AI N/A -217.80% -174.57% Telesis Bio -336.59% N/A -61.89%

Bullfrog AI (BFRG) Competitors

$0.59 0.00 (-0.17%)

Closing price 08/7/2026 04:00 PM Eastern

Extended Trading

$0.60 +0.01 (+0.85%)

As of 08/7/2026 07:55 PM Eastern

Compare

BFRG vs. HBIO, BNGO, ISPC, VIVS, and TBIO

Should you buy Bullfrog AI stock or one of its competitors? MarketBeat compares Bullfrog AI with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Bullfrog AI include Harvard Bioscience (HBIO), Bionano Genomics (BNGO), iSpecimen (ISPC), VivoSim Labs (VIVS), and Telesis Bio (TBIO). These companies are all part of the "life sciences tools & services" industry.

How does Bullfrog AI compare to Harvard Bioscience?

Bullfrog AI (NASDAQ:BFRG) and Harvard Bioscience (NASDAQ:HBIO) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Bullfrog AI has a beta of -2.7, indicating that its stock price is 370% less volatile than the broader market. Comparatively, Harvard Bioscience has a beta of 1.49, indicating that its stock price is 49% more volatile than the broader market.

Harvard Bioscience has a consensus price target of $6.00, indicating a potential downside of 7.26%. Given Harvard Bioscience's stronger consensus rating and higher possible upside, analysts clearly believe Harvard Bioscience is more favorable than Bullfrog AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Harvard Bioscience	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

1.0% of Bullfrog AI shares are owned by institutional investors. Comparatively, 80.9% of Harvard Bioscience shares are owned by institutional investors. 14.7% of Bullfrog AI shares are owned by insiders. Comparatively, 17.0% of Harvard Bioscience shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Bullfrog AI has a net margin of 0.00% compared to Harvard Bioscience's net margin of -11.44%. Harvard Bioscience's return on equity of -25.78% beat Bullfrog AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	-217.80%	-174.57%
Harvard Bioscience	-11.44%	-25.78%	-4.37%

In the previous week, Bullfrog AI's average media sentiment score of 0.00 equaled Harvard Bioscience'saverage media sentiment score.

Company	Overall Sentiment
Bullfrog AI	Neutral
Harvard Bioscience	Neutral

Bullfrog AI has higher earnings, but lower revenue than Harvard Bioscience. Harvard Bioscience is trading at a lower price-to-earnings ratio than Bullfrog AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$120K	91.16	-$6.50M	-$0.54	N/A
Harvard Bioscience	$86.55M	0.34	-$56.70M	-$2.17	N/A

Summary

Harvard Bioscience beats Bullfrog AI on 9 of the 14 factors compared between the two stocks.

How does Bullfrog AI compare to Bionano Genomics?

Bionano Genomics (NASDAQ:BNGO) and Bullfrog AI (NASDAQ:BFRG) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

Bullfrog AI has a net margin of 0.00% compared to Bionano Genomics' net margin of -109.94%. Bionano Genomics' return on equity of -71.38% beat Bullfrog AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bionano Genomics	-109.94%	-71.38%	-43.07%
Bullfrog AI	N/A	-217.80%	-174.57%

11.4% of Bionano Genomics shares are owned by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are owned by institutional investors. 0.7% of Bionano Genomics shares are owned by company insiders. Comparatively, 14.7% of Bullfrog AI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Bionano Genomics has a beta of 1.63, suggesting that its stock price is 63% more volatile than the broader market. Comparatively, Bullfrog AI has a beta of -2.7, suggesting that its stock price is 370% less volatile than the broader market.

Bionano Genomics currently has a consensus price target of $6.00, suggesting a potential upside of 417.24%. Given Bionano Genomics' stronger consensus rating and higher possible upside, equities research analysts plainly believe Bionano Genomics is more favorable than Bullfrog AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bionano Genomics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Bullfrog AI	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Bullfrog AI has lower revenue, but higher earnings than Bionano Genomics. Bullfrog AI is trading at a lower price-to-earnings ratio than Bionano Genomics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bionano Genomics	$28.51M	0.47	-$26.40M	-$4.37	N/A
Bullfrog AI	$120K	91.16	-$6.50M	-$0.54	N/A

In the previous week, Bionano Genomics had 2 more articles in the media than Bullfrog AI. MarketBeat recorded 2 mentions for Bionano Genomics and 0 mentions for Bullfrog AI. Bionano Genomics' average media sentiment score of 0.00 equaled Bullfrog AI'saverage media sentiment score.

Company	Overall Sentiment
Bionano Genomics	Neutral
Bullfrog AI	Neutral

Summary

Bionano Genomics beats Bullfrog AI on 10 of the 15 factors compared between the two stocks.

How does Bullfrog AI compare to iSpecimen?

Bullfrog AI (NASDAQ:BFRG) and iSpecimen (NASDAQ:ISPC) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, dividends, risk, institutional ownership, media sentiment and analyst recommendations.

Bullfrog AI has higher earnings, but lower revenue than iSpecimen. Bullfrog AI is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$120K	91.16	-$6.50M	-$0.54	N/A
iSpecimen	$1.93M	1.75	-$10.49M	-$72.26	N/A

Bullfrog AI has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. Bullfrog AI's return on equity of -217.80% beat iSpecimen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	-217.80%	-174.57%
iSpecimen	-1,080.16%	-584.65%	-142.48%

Bullfrog AI has a beta of -2.7, indicating that its share price is 370% less volatile than the broader market. Comparatively, iSpecimen has a beta of 1.66, indicating that its share price is 66% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
iSpecimen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

1.0% of Bullfrog AI shares are owned by institutional investors. Comparatively, 13.6% of iSpecimen shares are owned by institutional investors. 14.7% of Bullfrog AI shares are owned by company insiders. Comparatively, 12.2% of iSpecimen shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, iSpecimen had 4 more articles in the media than Bullfrog AI. MarketBeat recorded 4 mentions for iSpecimen and 0 mentions for Bullfrog AI. Bullfrog AI's average media sentiment score of 0.00 equaled iSpecimen'saverage media sentiment score.

Company	Overall Sentiment
Bullfrog AI	Neutral
iSpecimen	Neutral

Summary

Bullfrog AI beats iSpecimen on 7 of the 13 factors compared between the two stocks.

How does Bullfrog AI compare to VivoSim Labs?

Bullfrog AI (NASDAQ:BFRG) and VivoSim Labs (NASDAQ:VIVS) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

In the previous week, VivoSim Labs had 3 more articles in the media than Bullfrog AI. MarketBeat recorded 3 mentions for VivoSim Labs and 0 mentions for Bullfrog AI. VivoSim Labs' average media sentiment score of 0.28 beat Bullfrog AI's score of 0.00 indicating that VivoSim Labs is being referred to more favorably in the news media.

Company	Overall Sentiment
Bullfrog AI	Neutral
VivoSim Labs	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
VivoSim Labs	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Bullfrog AI has a net margin of 0.00% compared to VivoSim Labs' net margin of -10,567.17%. Bullfrog AI's return on equity of -217.80% beat VivoSim Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	-217.80%	-174.57%
VivoSim Labs	-10,567.17%	-277.62%	-153.77%

Bullfrog AI has a beta of -2.7, indicating that its stock price is 370% less volatile than the broader market. Comparatively, VivoSim Labs has a beta of 1.47, indicating that its stock price is 47% more volatile than the broader market.

Bullfrog AI has higher earnings, but lower revenue than VivoSim Labs. Bullfrog AI is trading at a lower price-to-earnings ratio than VivoSim Labs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$120K	91.16	-$6.50M	-$0.54	N/A
VivoSim Labs	$130K	12.56	-$13.84M	-$5.36	N/A

1.0% of Bullfrog AI shares are owned by institutional investors. Comparatively, 8.2% of VivoSim Labs shares are owned by institutional investors. 14.7% of Bullfrog AI shares are owned by company insiders. Comparatively, 2.5% of VivoSim Labs shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Bullfrog AI and VivoSim Labs tied by winning 7 of the 14 factors compared between the two stocks.

How does Bullfrog AI compare to Telesis Bio?

Bullfrog AI (NASDAQ:BFRG) and Telesis Bio (NASDAQ:TBIO) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings.

Bullfrog AI has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Telesis Bio's return on equity of 0.00% beat Bullfrog AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	-217.80%	-174.57%
Telesis Bio	-336.59%	N/A	-61.89%

Bullfrog AI has higher earnings, but lower revenue than Telesis Bio. Bullfrog AI is trading at a lower price-to-earnings ratio than Telesis Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$120K	91.16	-$6.50M	-$0.54	N/A
Telesis Bio	$225.09M	0.00	-$47.72M	-$20.52	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Telesis Bio	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

1.0% of Bullfrog AI shares are owned by institutional investors. Comparatively, 37.6% of Telesis Bio shares are owned by institutional investors. 14.7% of Bullfrog AI shares are owned by insiders. Comparatively, 24.5% of Telesis Bio shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Bullfrog AI's average media sentiment score of 0.00 equaled Telesis Bio'saverage media sentiment score.

Company	Overall Sentiment
Bullfrog AI	Neutral
Telesis Bio	Neutral

Bullfrog AI has a beta of -2.7, suggesting that its stock price is 370% less volatile than the broader market. Comparatively, Telesis Bio has a beta of 2.43, suggesting that its stock price is 143% more volatile than the broader market.

Summary

Telesis Bio beats Bullfrog AI on 7 of the 12 factors compared between the two stocks.

Get Bullfrog AI News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BFRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BFRG vs. The Competition

Export

Metric	Bullfrog AI	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$10.96M	$9.35B	$6.94B	$12.86B
Dividend Yield	N/A	1.46%	2.59%	10.09%
P/E Ratio	-1.09	63.06	270.26	25.05
Price / Sales	91.16	105.73	601.25	100.65
Price / Cash	N/A	25.91	71.46	49.72
Price / Book	3.11	38.45	13.25	6.21
Net Income	-$6.50M	$56.66B	$3.45B	$342.45M
7 Day Performance	6.31%	5.09%	4.63%	4.41%
1 Month Performance	-13.20%	2.65%	-0.81%	-0.28%
1 Year Performance	-53.54%	21.81%	77.73%	22.60%

Bullfrog AI Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BFRG Bullfrog AI	1.0643 of 5 stars	$0.59 -0.2%	N/A	-54.6%	$10.96M	$120K	N/A	4	Upcoming Earnings
HBIO Harvard Bioscience	0.8139 of 5 stars	$6.40 +1.4%	$6.00 -6.3%	+25.9%	$28.86M	$86.55M	N/A	490	Upcoming Earnings
BNGO Bionano Genomics	1.8191 of 5 stars	$1.08 -4.0%	$6.00 +458.1%	-60.4%	$12.34M	$28.51M	N/A	300	News Coverage Upcoming Earnings
ISPC iSpecimen	0.1691 of 5 stars	$2.05 -4.7%	N/A	-96.9%	$3.12M	$1.93M	N/A	60	News Coverage
VIVS VivoSim Labs	0.9326 of 5 stars	$0.37 +1.0%	N/A	-73.2%	$1.30M	$131K	N/A	20

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BFRG) was last updated on 8/8/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bullfrog AI (BFRG) Competitors

BFRG vs. HBIO, BNGO, ISPC, VIVS, and TBIO

How does Bullfrog AI compare to Harvard Bioscience?

Summary

How does Bullfrog AI compare to Bionano Genomics?

Summary

How does Bullfrog AI compare to iSpecimen?

Summary

How does Bullfrog AI compare to VivoSim Labs?

Summary

How does Bullfrog AI compare to Telesis Bio?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BFRG vs. The Competition

Bullfrog AI Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bullfrog AI (BFRG) Competitors

BFRG vs. HBIO, BNGO, ISPC, VIVS, and TBIO

How does Bullfrog AI compare to Harvard Bioscience?

Which has more risk & volatility, BFRG or HBIO?

Do analysts rate BFRG or HBIO?

Do institutionals & insiders believe in BFRG or HBIO?

Is BFRG or HBIO more profitable?

Does the media prefer BFRG or HBIO?

Which has stronger valuation and earnings, BFRG or HBIO?

Summary

How does Bullfrog AI compare to Bionano Genomics?

Is BNGO or BFRG more profitable?

Do institutionals and insiders have more ownership in BNGO or BFRG?

Which has more volatility and risk, BNGO or BFRG?

Do analysts recommend BNGO or BFRG?

Which has stronger earnings and valuation, BNGO or BFRG?

Does the media refer more to BNGO or BFRG?

Summary

How does Bullfrog AI compare to iSpecimen?

Which has stronger earnings and valuation, BFRG or ISPC?

Is BFRG or ISPC more profitable?

Which has more volatility and risk, BFRG or ISPC?

Do analysts rate BFRG or ISPC?

Do institutionals and insiders have more ownership in BFRG or ISPC?

Does the media favor BFRG or ISPC?

Summary

How does Bullfrog AI compare to VivoSim Labs?

Does the media prefer BFRG or VIVS?

Do analysts prefer BFRG or VIVS?

Is BFRG or VIVS more profitable?

Which has more risk and volatility, BFRG or VIVS?

Which has stronger earnings and valuation, BFRG or VIVS?

Do insiders and institutionals hold more shares of BFRG or VIVS?

Summary

How does Bullfrog AI compare to Telesis Bio?

Is BFRG or TBIO more profitable?

Which has better valuation and earnings, BFRG or TBIO?

Do analysts prefer BFRG or TBIO?

Do institutionals & insiders hold more shares of BFRG or TBIO?

Does the media prefer BFRG or TBIO?

Which has more volatility and risk, BFRG or TBIO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BFRG vs. The Competition

Bullfrog AI Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools